Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Holst

Showing results (181-190 of 1,570) with videos related to

Pageof 157
Sort By:
FEBS Letters|September 25, 1995
Human colon produces fully processed glucagon-like peptide-1 (7-36) amideC F Deacon, A H Johnsen, J J Holst
Digestive Diseases and Sciences|May 1, 1995
Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humansP Layer, J J Holst, D Grandt, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1995
Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivoC F Deacon, A H Johnsen, J J Holst
Acta Chirurgica Scandinavica. Supplementum|January 1, 1984
Pirenzepine depresses plasma noradrenaline in duodenal ulcer patientsH Graffner, L O Farnebo, J Holst, et al.
The Journal of Clinical Investigation|February 1, 1991
Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginineC Orskov, J Jeppesen, S Madsbad, et al.
Histochemistry|January 1, 1987
Immunohistochemical detection of ganglia in the rat stomach serosa, containing neurons immunoreactive for gastrin-releasing peptide and vasoactive intestinal peptideT Skak-Nielsen, S S Poulsen, J J Holst
Neonatology|March 9, 2007
Glucagon-like peptide-2 in umbilical cord blood from mature infantsSusan Bodé, Bolette Hartmann, Jens J Holst, et al.
Diabetes, Obesity & Metabolism|November 21, 2013
Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitusS S Torekov, J J Holst, M R Ehlers
Diabetes|May 20, 1998
Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pigC F Deacon, T E Hughes, J J Holst
Scandinavian Journal of Gastroenterology|October 1, 1998
Glucagon-like peptide-2 inhibits centrally induced antral motility in pigsM Wøjdemann, A Wettergren, B Hartmann, et al.
Pageof 157

Showing results (181-190 of 1,570) with videos related to

Sort By:
Pageof 157
FEBS Letters|September 25, 1995
Human colon produces fully processed glucagon-like peptide-1 (7-36) amideC F Deacon, A H Johnsen, J J Holst
Digestive Diseases and Sciences|May 1, 1995
Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humansP Layer, J J Holst, D Grandt, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1995
Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivoC F Deacon, A H Johnsen, J J Holst
Acta Chirurgica Scandinavica. Supplementum|January 1, 1984
Pirenzepine depresses plasma noradrenaline in duodenal ulcer patientsH Graffner, L O Farnebo, J Holst, et al.
The Journal of Clinical Investigation|February 1, 1991
Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginineC Orskov, J Jeppesen, S Madsbad, et al.
Histochemistry|January 1, 1987
Immunohistochemical detection of ganglia in the rat stomach serosa, containing neurons immunoreactive for gastrin-releasing peptide and vasoactive intestinal peptideT Skak-Nielsen, S S Poulsen, J J Holst
Neonatology|March 9, 2007
Glucagon-like peptide-2 in umbilical cord blood from mature infantsSusan Bodé, Bolette Hartmann, Jens J Holst, et al.
Diabetes, Obesity & Metabolism|November 21, 2013
Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitusS S Torekov, J J Holst, M R Ehlers
Diabetes|May 20, 1998
Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pigC F Deacon, T E Hughes, J J Holst
Scandinavian Journal of Gastroenterology|October 1, 1998
Glucagon-like peptide-2 inhibits centrally induced antral motility in pigsM Wøjdemann, A Wettergren, B Hartmann, et al.
Pageof 157